Trial intelligence / Profile preview

Ganfort versus Duotrav after prior Xalacom treatment in open-angle and pseudoexfoliative glaucoma

2007-004023-38Phase 4Completed

Sponsor
Fondazione G.B. Bietti-IRCCS
Start
Nov 2007
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, double-blind trial of bimatoprost + timolol and travoprost in open-angle glaucoma (OAG) and Glaucoma (2 arms), sponsored by Fondazione G.B. Bietti-IRCCS. Started Nov 2007; status: completed.

02

Drugs

bimatoprost + timololtravoprost
03

Conditions

open-angle glaucoma (OAG)Glaucoma

Beyond the preview

Go deeper on 2007-004023-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004023-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call